CTLA4 and breast cancer: Finally, we have determined that neoplastic cell-intrinsic CTLA-4, PCDC1 (PD1), CD274 (PD-L1), and PDCD1LG2 (PD-L2) expression is dynamic and varies depending on BC immunophenotype and tumor-immune cell interactions.